Congenica Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Congenica Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11264
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug development, and support clinical trials, among others. Congenica offers services such as clinical and genomic data, clinical reporting, and variant interpretation, among others. The company’s clinical reporting secures share access of genotype and phenotype and generates customisable reports. It partners with clinical research and healthcare providers, diagnostic, and pharmaceutical companies and charities and patient advocacy groups. Congenica is headquartered in Cambridge, the UK.

Congenica Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Congenica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Congenica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Congenica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Congenica Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Congenica Raises USD10 Million in Series B Financing 11
Congenica Raises USD3.2 Million in Series A Financing 12
Congenica Raises USD1.56 Million in Seed Financing 13
Partnerships 14
Congenica Enters into Agreement with GenomOncology 14
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 15
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 16
Congenica Ltd – Key Competitors 17
Congenica Ltd – Key Employees 18
Congenica Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
Aug 28, 2018: Congenica names Wendy Britten as Chief Financial Officer 20
Jan 25, 2018: Congenica Appoints New CEO to Drive Global Expansion of Clinical Genomics Business 21
Jan 17, 2017: Congenica appoints new chief business officer 22
Jan 17, 2017: Congenica Expands in North America with Strategic Appointment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Congenica Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Congenica Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Congenica Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Congenica Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Congenica Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Congenica Raises USD10 Million in Series B Financing 11
Congenica Raises USD3.2 Million in Series A Financing 12
Congenica Raises USD1.56 Million in Seed Financing 13
Congenica Enters into Agreement with GenomOncology 14
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 15
Congenica Enters into Co-Development Agreement with Northern Health Science Alliance 16
Congenica Ltd, Key Competitors 17
Congenica Ltd, Key Employees 18

List of Figures
Congenica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Congenica Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Congenica Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Congenica Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Congenica Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medrobotics Corp:製品パイプライン分析
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Vascular Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary Vascular Solutions Inc (Vascular Solutions), a subsidiary of Teleflex Inc, is a medical device company that develops and markets clinical solutions for coronary and peripheral vascular procedures. The company’s portfolio spans various types of catheters used for simultaneous pressure measure …
  • GTT Communications Inc (GTT):企業の財務・戦略的SWOT分析
    GTT Communications Inc (GTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ivanhoe Mines Ltd:企業のM&A・事業提携・投資動向
    Ivanhoe Mines Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ivanhoe Mines Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Saudi Arabian Mining Co:企業の戦略・SWOT・財務情報
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Infant Bacterial Therapeutics AB (IBT B):製薬・医療:M&Aディール及び事業提携情報
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • West Corporation:企業の戦略的SWOT分析
    West Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Haitong Securities Co., Ltd.
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Versum Materials, Inc. (VSM):企業の財務・戦略的SWOT分析
    Versum Materials, Inc. (VSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Wesco Aircraft Holdings Inc:企業の戦略・SWOT・財務分析
    Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Wesco Aircraft Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Pep Boys – Manny, Moe & Jack of California:企業の戦略的SWOT分析
    The Pep Boys - Manny, Moe & Jack of California - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Suncor Energy Inc (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Suncor Energy Inc (Suncor) is an integrated energy company that mainly focuses on the development of Athabasca oil sands. It carries out development and up gradation of oil sands; offshore and onshore oil and gas production; refining of crude oil and marketing of petroleum and petrochemical …
  • AbbVie Inc (ABBV)-医療機器分野:企業M&A・提携分析
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that carries out the research, development, manufacture and commercialization of advanced therapies to treat complex and serious diseases. The company focuses on providing drugs in immunology, cancer, neuroscience and virology …
  • China Agri-Industries Holdings Ltd (606):企業の財務・戦略的SWOT分析
    China Agri-Industries Holdings Ltd (606) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • One Call Care Management Inc-医療機器分野:企業M&A・提携分析
    Summary One Call Care Management Inc (OCCM), formerly One Call Medical Inc is a healthcare technology provider that offers specialized cost containment services. The company provides diagnostics, dental, transport, complex home care, equipment and physical therapy. It offers value added service and …
  • Synthetic Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Synthetic Genomics Inc (Synthetic Genomics) is a provider of synthetic biology and synthetic genomics solutions. The company offers DNA synthesis services, instrumentation, reagents, and bioinformatics services and software packages. It offers solutions in genomics research, bioproduction, a …
  • Heartland Consumers Power District:企業の戦略的SWOT分析
    Heartland Consumers Power District - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆